These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 20849099

  • 21. Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan.
    Yuan ZX, Zhang ZR, Zhu D, Sun X, Gong T, Liu J, Luan CT.
    Mol Pharm; 2009; 6(1):305-14. PubMed ID: 19035784
    [Abstract] [Full Text] [Related]

  • 22. Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector.
    Gao S, Chen J, Dong L, Ding Z, Yang YH, Zhang J.
    Eur J Pharm Biopharm; 2005 Aug; 60(3):327-34. PubMed ID: 15894474
    [Abstract] [Full Text] [Related]

  • 23. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
    Lin YH, Mi FL, Chen CT, Chang WC, Peng SF, Liang HF, Sung HW.
    Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
    [Abstract] [Full Text] [Related]

  • 24. Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo.
    Dong L, Gao S, Diao H, Chen J, Zhang J.
    J Biomed Mater Res A; 2008 Mar 01; 84(3):777-84. PubMed ID: 17635017
    [Abstract] [Full Text] [Related]

  • 25. Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats.
    Anwar M, Warsi MH, Mallick N, Akhter S, Gahoi S, Jain GK, Talegaonkar S, Ahmad FJ, Khar RK.
    Eur J Pharm Sci; 2011 Oct 09; 44(3):241-9. PubMed ID: 21864678
    [Abstract] [Full Text] [Related]

  • 26. Promising interaction between nanoencapsulated lutein with low molecular weight chitosan: characterization and bioavailability of lutein in vitro and in vivo.
    Arunkumar R, Harish Prashanth KV, Baskaran V.
    Food Chem; 2013 Nov 01; 141(1):327-37. PubMed ID: 23768365
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
    Wu ZH, Ping QN, Wei Y, Lai JM.
    Acta Pharmacol Sin; 2004 Jul 01; 25(7):966-72. PubMed ID: 15210073
    [Abstract] [Full Text] [Related]

  • 29. Formulation and characterization of an oily-based system for oral delivery of insulin.
    Elsayed A, Remawi MA, Qinna N, Farouk A, Badwan A.
    Eur J Pharm Biopharm; 2009 Oct 01; 73(2):269-79. PubMed ID: 19508890
    [Abstract] [Full Text] [Related]

  • 30. A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats.
    Yao HT, Huang SY, Chiang MT.
    Food Chem Toxicol; 2008 May 01; 46(5):1525-34. PubMed ID: 18255211
    [Abstract] [Full Text] [Related]

  • 31. [The enhancing effect of tomato lectin modified liposomes of insulin on oral absorption in mice].
    Zhang N, Ping QN, Xu WF.
    Yao Xue Xue Bao; 2004 May 01; 39(5):380-4. PubMed ID: 15338884
    [Abstract] [Full Text] [Related]

  • 32. In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan.
    Krauland AH, Leitner VM, Grabovac V, Bernkop-Schnürch A.
    J Pharm Sci; 2006 Nov 01; 95(11):2463-72. PubMed ID: 16886206
    [Abstract] [Full Text] [Related]

  • 33. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L, Ding J, He C, Cui L, Tang C, Yin C.
    Biomaterials; 2009 Oct 01; 30(29):5691-700. PubMed ID: 19615735
    [Abstract] [Full Text] [Related]

  • 34. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.
    Sonaje K, Lin KJ, Wey SP, Lin CK, Yeh TH, Nguyen HN, Hsu CW, Yen TC, Juang JH, Sung HW.
    Biomaterials; 2010 Sep 01; 31(26):6849-58. PubMed ID: 20619787
    [Abstract] [Full Text] [Related]

  • 35. The stability of insulin-loaded polybutylcyanoacrylate nanoparticles in an oily medium and the hypoglycemic effect in diabetic rats.
    Hou ZQ, Zhang ZX, Xu ZH, Zhang H, Tong ZF, Leng YS.
    Yao Xue Xue Bao; 2005 Jan 01; 40(1):57-64. PubMed ID: 15881329
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats.
    Ma Z, Lim TM, Lim LY.
    Int J Pharm; 2005 Apr 11; 293(1-2):271-80. PubMed ID: 15778065
    [Abstract] [Full Text] [Related]

  • 37. Development of a Gas Empowered Drug Delivery system for peptide delivery in the small intestine.
    Sadeghi AM, Avadi MR, Ejtemaimehr Sh, Abashzadeh Sh, Partoazar A, Dorkoosh F, Faghihi M, Rafiee-Tehrani M, Junginger HE.
    J Control Release; 2009 Feb 20; 134(1):11-7. PubMed ID: 19014985
    [Abstract] [Full Text] [Related]

  • 38. Multifunctional polyelectrolyte microparticles for oral insulin delivery.
    Balabushevich NG, Pechenkin MA, Shibanova ED, Volodkin DV, Mikhalchik EV.
    Macromol Biosci; 2013 Oct 20; 13(10):1379-88. PubMed ID: 23861285
    [Abstract] [Full Text] [Related]

  • 39. Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin.
    Kashyap N, Viswanad B, Sharma G, Bhardwaj V, Ramarao P, Ravi Kumar MN.
    Biomaterials; 2007 Apr 20; 28(11):2051-60. PubMed ID: 17240443
    [Abstract] [Full Text] [Related]

  • 40. [Enhancing effect of Ulex europaeus agglutinin I modified liposomes on oral insulin absorption in mice].
    Zhang N, Ping QN, Xu WF.
    Yao Xue Xue Bao; 2004 Dec 20; 39(12):1006-10. PubMed ID: 15813031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.